JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2005, 54(4):159-162

Advances in Enantioselective TLC of Therapeutic Agents

J. Šubert1, K. Šlais2
1 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav chemických léčiv
2 Akademie věd ČR Brno, Ústav analytické chemie

Enantioselective TLC represents a still developing field of analysis of therapeutic agents. In recent years, similarly as in HPLC, mainly direct separations of enantiomers without their preceding derivatization have been published, preferentially using chiral stationary phases, separations with a chiral selector in the mobile phase being less frequent. In the future, a larger choice of commercially available chiral stationary phases could contribute to a more widespread use of enantioselective TLC.

Keywords: enantiomers; TLC; therapeutic agents

Received: September 10, 2004; Accepted: December 14, 2004; Published: April 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šubert J, Šlais K. Advances in Enantioselective TLC of Therapeutic Agents. Čes. slov. farm. 2005;54(4):159-162.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Maier, N. M., Franco, P., Lindner, W.: J. Chromatogr. A, 200l; 906, 3-33.
    2. Stefan, R.- I., van Staden, J. F., Aboul - Enein, H. Y.: Cryst. Eng., 2001; 4, 113-118. Go to original source...
    3. Gubitz, G., Schmid, M. G.: Biopharm. Drug. Dispos., 2001; 22, 291-336. Go to original source... Go to PubMed...
    4. Bereznitski, Y., Thompson, R., O'Neill, E., Grinberg, N.: J. AOAC Int., 2001; 84, 1242-1251.
    5. Šubert, J., Šlais, K.: Pharmazie, 2001; 56, 355-360.
    6. Zhu, Q., Deng, Q., Zeng, L.: Yaowu Fenxi Zazhi, 2002; 22, 155-158.
    7. Bhushan, R., Martens, J.: Biomed. Chromatogr., 2001; 15, 155-165. Go to original source... Go to PubMed...
    8. Gocan, S.: J. Chromatogr. Sci., 2002; 40, 538-549. Go to original source... Go to PubMed...
    9. Lepri, L., Del Bubba, M., Cincinelli, A., Boddi, L.: J. Planar. Chromatogr., 2001; 14, 134-136.
    10. Xu, L, He, J., Liu, L., Deng, Q. Y.: Fenxi Ceshi Xuebao, 2003; 22 (2), 1-4.
    11. Xu, L., Liu, L., He, J., Ma, G., Deng, Q.: Zhongshan Daxue Xuebao, Ziran Kexueban Guangzhou, 2002; 41, 115-117.
    12. Xu, L., He, J., Liu, L., Ma, G., Deng, Q.: Fenxi Huaxue, 2003; 31, 537-540. Go to original source...
    13. Kubota, T., Yamamoto, C., Okamoto, Y.: J. Am. Chem. Soc., 2000; 122, 4056-4059. Go to original source...
    14. Zhu, Q., Yu, P., Deng, Q., Zeng, L.: J. Planar Chromatogr., 2001; 14, 137-139. Go to original source...
    15. Zhu, Q., Ma, G., Deng, Q., Zeng, L.: Fenxi Huaxue, 2000; 28, 349-352.
    16. Aboul-Enein, H. Y., El-Awady, M. I., Heard, C. M.: Pharmazie, 2002; 57, 169-171. Go to original source... Go to PubMed...
    17. Suedee, R., Srichana, T., Saelim, J., Thavonpibulbut, T.: J. Planar Chromatogr., 2001; 14, 194-198.
    18. Bhushan, R., Martens, J., Arora, M.: Biomed. Chromatogr., 2001; 15, 151-154. Go to original source... Go to PubMed...
    19. Bhushan, R., Arora, M.: Ibid., 2001; 15, 433-436.
    20. Bhushan, R., Arora, M.: Ibid., 2003; 17, 226-230.
    21. Aboul-Enein, H. Y., El-Awady, M., I., Heard, C. M.: Biomed. Chromatogr., 2003; 17, 325-334. Go to original source... Go to PubMed...
    22. Sajewicz, M., Pietka, R., Kowalska, I.: J. Planar Chromatogr., 2004; 17, 173-176. Go to original source...
    23. Mielcarek, J.: Drug Dev. Ind. Pharm., 2001; 27, 175-179. Go to original source... Go to PubMed...
    24. Aboul-Enein, H. Y., El-Awady, M. I., Heard, C. M.: J. Liq. Chromatogr., Rel. Technol., 2000; 23, 2715-2726. Go to original source...
    25. Li, G., Huang, M., Yang, G. et al.: Shandong Daxue Xuebao, Ziran Kexueban, 2001; 36, 429-432.
    26. Zhu, C., Zhao, J., Huang, M., Wang, M.: Shandong Daxue Xuebao, Lixueban, 2003; 86-88.
    27. Li, G., Huang, M., Yang, G. et al.: Sepu, 1999; 17, 215-216. Go to original source... Go to PubMed...
    28. Lepri, L., Boddi, L., Del Bubba M., Cincinelli, A.: Biomed. Chromatogr., 2001; 15, 196-201. Go to original source... Go to PubMed...
    29. Görög, S.: In: Detection - Oriented Derivatization Techniques in Liquid Chromatography, Chromatogr. Sci. Ser., Vol. 48 (Lingeman, H., Underberg, W. J. M., eds.), New York and Basel, Marcel Dekker, 1990, s. 193-216.
    30. LeFevre, J. W.: J. Chromatogr. A, 1993; 653, 293-302. Go to original source...
    31. LeFevre, J. W.: J. Chem. Educ., 1998; 75, 1287-1290. Go to original source...
    32. LeFevre, J. W., Bonzagni, N. J., Chappell, L. L. et al.: J. Labelled Compd. Radiopharm., 1998; 41, 477-489. Go to original source...
    33. LeFevre, J. W., Rogers, E. D., Pico, L. L., Botting, C. L.: Chromatographia, 2000; 52, 648-652. Go to original source...
    34. LeFevre, J. W., Gublo, E. J., Botting, C. et al.: J. Planar. Chromatogr., 2000; 13, 160-165. Go to original source...
    35. Nagata, Y., Iida, T., Sakai, M.: J. Mol. Catal. B: Enzymatic, 2001; 12, 105-108. Go to original source...
    36. Heuser, D., Meads, O.: J. Planar Chromatogr., 1993; 6, 324-325.
    37. Spell, J. C., Stewart, J. T.: Ibid., 1997; 10, 222-224.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.